In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay
Intratumoral hypoxia changes the metabolism of gliomas, leading to a more aggressive phenotype with increased resistance to radio- and chemotherapy. Hypoxia triggers a signaling cascade with hypoxia-inducible factor (HIF) as a key regulator. We monitored activation of the HIF pathway longitudinally...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2014-11-01
|
| Series: | Molecular Imaging |
| Online Access: | https://doi.org/10.2310/7290.2014.00029 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841563143843610624 |
|---|---|
| author | Sandra Bürgi Aline Seuwen Ruth Keist Johannes vom Berg Joanes Grandjean Markus Rudin |
| author_facet | Sandra Bürgi Aline Seuwen Ruth Keist Johannes vom Berg Joanes Grandjean Markus Rudin |
| author_sort | Sandra Bürgi |
| collection | DOAJ |
| description | Intratumoral hypoxia changes the metabolism of gliomas, leading to a more aggressive phenotype with increased resistance to radio- and chemotherapy. Hypoxia triggers a signaling cascade with hypoxia-inducible factor (HIF) as a key regulator. We monitored activation of the HIF pathway longitudinally in murine glioma tumors. GL261 cells, stably transfected with a luciferase reporter driven under the control of a promoter comprising the HIF target gene motive hypoxia response element, were implanted either subcutaneously or orthotopically. In vivo experiments were carried out using bioluminescence imaging. Tumors were subsequently analyzed using immunofluorescence staining for hypoxia, endothelial cells, tumor perfusion, and glucose transporter expression. Transient upregulation of the HIF signaling was observed in both subcutaneous and orthotopic gliomas. Immunofluorescence staining confirmed hypoxic regions in subcutaneous and, to a lesser extent, intracranial tumors. Subcutaneous tumors showed substantial necrosis, which might contribute to the decreased bioluminescence output observed toward the end of the experiment. Orthotopic tumors were less hypoxic than subcutaneous ones and did not develop extensive necrotic areas. Although this may be the result of the overall smaller size of orthotopic tumors, it might also reflect differences in the local environment, such as the better intrinsic vascularization of brain tissue compared to the subcutaneous tissue compartment. |
| format | Article |
| id | doaj-art-61bad6b9957e494090da52217e3098b2 |
| institution | Kabale University |
| issn | 1536-0121 |
| language | English |
| publishDate | 2014-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Molecular Imaging |
| spelling | doaj-art-61bad6b9957e494090da52217e3098b22025-01-03T00:11:34ZengSAGE PublishingMolecular Imaging1536-01212014-11-011310.2310/7290.2014.0002910.2310_7290.2014.00029In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene AssaySandra BürgiAline SeuwenRuth KeistJohannes vom BergJoanes GrandjeanMarkus RudinIntratumoral hypoxia changes the metabolism of gliomas, leading to a more aggressive phenotype with increased resistance to radio- and chemotherapy. Hypoxia triggers a signaling cascade with hypoxia-inducible factor (HIF) as a key regulator. We monitored activation of the HIF pathway longitudinally in murine glioma tumors. GL261 cells, stably transfected with a luciferase reporter driven under the control of a promoter comprising the HIF target gene motive hypoxia response element, were implanted either subcutaneously or orthotopically. In vivo experiments were carried out using bioluminescence imaging. Tumors were subsequently analyzed using immunofluorescence staining for hypoxia, endothelial cells, tumor perfusion, and glucose transporter expression. Transient upregulation of the HIF signaling was observed in both subcutaneous and orthotopic gliomas. Immunofluorescence staining confirmed hypoxic regions in subcutaneous and, to a lesser extent, intracranial tumors. Subcutaneous tumors showed substantial necrosis, which might contribute to the decreased bioluminescence output observed toward the end of the experiment. Orthotopic tumors were less hypoxic than subcutaneous ones and did not develop extensive necrotic areas. Although this may be the result of the overall smaller size of orthotopic tumors, it might also reflect differences in the local environment, such as the better intrinsic vascularization of brain tissue compared to the subcutaneous tissue compartment.https://doi.org/10.2310/7290.2014.00029 |
| spellingShingle | Sandra Bürgi Aline Seuwen Ruth Keist Johannes vom Berg Joanes Grandjean Markus Rudin In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay Molecular Imaging |
| title | In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay |
| title_full | In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay |
| title_fullStr | In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay |
| title_full_unstemmed | In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay |
| title_short | In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay |
| title_sort | in vivo imaging of hypoxia inducible factor regulation in a subcutaneous and orthotopic gl261 glioma tumor model using a reporter gene assay |
| url | https://doi.org/10.2310/7290.2014.00029 |
| work_keys_str_mv | AT sandraburgi invivoimagingofhypoxiainduciblefactorregulationinasubcutaneousandorthotopicgl261gliomatumormodelusingareportergeneassay AT alineseuwen invivoimagingofhypoxiainduciblefactorregulationinasubcutaneousandorthotopicgl261gliomatumormodelusingareportergeneassay AT ruthkeist invivoimagingofhypoxiainduciblefactorregulationinasubcutaneousandorthotopicgl261gliomatumormodelusingareportergeneassay AT johannesvomberg invivoimagingofhypoxiainduciblefactorregulationinasubcutaneousandorthotopicgl261gliomatumormodelusingareportergeneassay AT joanesgrandjean invivoimagingofhypoxiainduciblefactorregulationinasubcutaneousandorthotopicgl261gliomatumormodelusingareportergeneassay AT markusrudin invivoimagingofhypoxiainduciblefactorregulationinasubcutaneousandorthotopicgl261gliomatumormodelusingareportergeneassay |